Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.

van Dijk SC, de Herder WW, Kwekkeboom DJ, Zillikens MC, Feelders RA, van Schaik RH, van Driel M, van Leeuwen JP.

Bone. 2012 Jun;50(6):1260-5. doi: 10.1016/j.bone.2012.02.637.

PMID:
22425693
2.

Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome.

Walsh JS, Newell-Price JD, DeBono M, Adaway J, Keevil B, Eastell R.

J Clin Endocrinol Metab. 2013 Jul;98(7):2902-7. doi: 10.1210/jc.2012-4174.

3.
4.
5.
6.

Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.

Zuetenhorst JM, Korse CM, Bonfrer JM, Peter E, Lamers CB, Taal BG.

Clin Chem. 2004 Sep;50(9):1634-9.

7.

Growth hormone and prolactin secretion in the carcinoid syndrome.

Feldman JM, Plonk JW, Bivens CH, Lebovitz HE, Handwerger S.

Am J Med Sci. 1975 May-Jun;269(3):333-47.

PMID:
125543
8.

Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.

Kema IP, de Vries EG, Schellings AM, Postmus PE, Muskiet FA.

Clin Chem. 1992 Apr;38(4):534-40.

9.

Discriminating capacity of indole markers in the diagnosis of carcinoid tumors.

Meijer WG, Kema IP, Volmer M, Willemse PH, de Vries EG.

Clin Chem. 2000 Oct;46(10):1588-96.

11.

Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy.

Shakir KM, Jasser MZ, Yoshihashi AK, Drake AJ 3rd, Eisold JF.

Mayo Clin Proc. 1996 Dec;71(12):1145-9.

PMID:
8945484
12.

Biochemical assessment of niacin deficiency among carcinoid cancer patients.

Shah GM, Shah RG, Veillette H, Kirkland JB, Pasieka JL, Warner RR.

Am J Gastroenterol. 2005 Oct;100(10):2307-14.

PMID:
16181385
13.

Biochemical bone turnover markers in patients with ankylosing spondylitis.

Yilmaz N, Ozaslan J.

Clin Rheumatol. 2000;19(2):92-8.

PMID:
10791618
14.

Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.

Mao C, el Attar A, Domenico DR, Kim K, Howard JM.

Int J Pancreatol. 1998 Apr;23(2):153-64. Review.

PMID:
9629513
15.

Urinary serotonin in the diagnosis of carcinoid tumors.

Feldman JM.

Clin Chem. 1986 May;32(5):840-4.

16.

[Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].

Moskwa A, Chojnacki J, Wiśiewska-Jarosińska M, Stec-Michalska K, Szadkowski K, Smigielski J, Chojnacki C.

Pol Merkur Lekarski. 2007 May;22(131):366-8. Polish.

PMID:
17679369
17.

Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.

van der Horst-Schrivers AN, Post WJ, Kema IP, Links TP, Willemse PH, Wymenga AN, de Vries EG.

Eur J Cancer. 2007 Dec;43(18):2651-7.

PMID:
17825550
18.

Automated on-line solid-phase extraction coupled with HPLC for measurement of 5-hydroxyindole-3-acetic acid in urine.

Mulder EJ, Oosterloo-Duinkerken A, Anderson GM, De Vries EG, Minderaa RB, Kema IP.

Clin Chem. 2005 Sep;51(9):1698-703.

19.

[The ectopic ACTH syndrome].

Penezić Z, Savić S, Vujović S, Tatić S, Ercegovac M, Drezgićc M.

Srp Arh Celok Lek. 2004 Jan-Feb;132(1-2):28-32. Serbian.

20.

Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease.

Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH.

Ann Clin Biochem. 2002 Nov;39(Pt 6):577-82.

PMID:
12564839
Items per page

Supplemental Content

Support Center